![]() Ventria Bioscience Ventria Bioscience develops life-saving medicines targeting inflammatory, infectious and gastrointestinal diseases. | ![]() GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. | ||
Founding Date | Founding Date 1993 | Founding Date 1990 | Founding Date 2012 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Junction City, US HQ Aurora, US | Locations Tokyo, JP HQ Dublin, IE Cambridge, GB London, GB | Locations South San Francisco, US HQ Paris, FR Berlin, DE Baar, CH London, GB |
Employees | Employees 244% decrease | Employees 387 | Employees 352106% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 697 m | Valuation ($) 4.4 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥29.6b (FY, 2025) | Revenue (est.) $194.7m (FY, 2021) |
Cost of goods | Cost of goods N/A | Cost of goods ¥7.3b (FY, 2025) | Cost of goods $3.3m (FY, 2021) |
Net income | Net income N/A | Net income (¥12.5b) (FY, 2025) | Net income ($303.1m) (FY, 2021) |
Funding | |||
Total funding raised | Total funding raised $ 7.7m | Total funding raised $ 65m | Total funding raised $ 88.7m |

Sosei Heptares is a biopharmaceutical company that specializes in drug development.
View company
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
View company